← Back to Search

Behavioral Intervention

START Program for Opioid Addiction (START Trial)

N/A
Waitlist Available
Led By Itai Danovitch, MD
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Admitted to an inpatient bed at Cedars-Sinai Medical Center (CSMC), University of New Mexico Hospital (UNM), or Baystate Health (BH)
Age 18 and older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

START Trial Summary

This trial is testing whether a collaborative care team can increase the use of two interventions - medication for opioid use disorder and discharge planning for those with opioid use disorder - and improve linkage to follow-up care.

Who is the study for?
This trial is for adults over 18 who are hospitalized with opioid use disorder (OUD) and not currently on FDA-approved medication for OUD. Participants must speak English or Spanish, be willing to do follow-up calls, and have a life expectancy of more than 6 months.Check my eligibility
What is being tested?
The START program is being tested at three hospitals. It involves an addiction specialist and care manager helping patients get medication for OUD and planning post-discharge care. Patients will either receive this special team support or usual care.See study design
What are the potential side effects?
Since the intervention focuses on collaborative care rather than a specific medical treatment, side effects may vary based on individual patient responses to medications used in their OUD treatment plan.

START Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently admitted as an inpatient at CSMC, UNM, or BH.
Select...
I am 18 years old or older.

START Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
In-hospital initiation of MOUD therapy
Linkage to follow-up OUD care
Secondary outcome measures
Any post-discharge MOUD utilization
OUD-specific discharge plan
Past 30-day number of days with any opioid use
+1 more

START Trial Design

2Treatment groups
Active Control
Group I: Substance Use Treatment and Recovery Team (START)Active Control1 Intervention
The intervention is administered to participants in this arm. Participants in this arm will work with the Substance Use Treatment and Recovery Team (START), a collaborative care team for inpatients with opioid use disorder.
Group II: Usual CareActive Control1 Intervention
Usual care for people with opioid use disorder.

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Science (NCATS)NIH
99 Previous Clinical Trials
36,049 Total Patients Enrolled
Cedars-Sinai Medical CenterLead Sponsor
497 Previous Clinical Trials
164,156 Total Patients Enrolled
RANDOTHER
137 Previous Clinical Trials
509,926 Total Patients Enrolled

Media Library

Substance Use Treatment and Recovery Team (START) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05086796 — N/A
Opioid Use Disorder Research Study Groups: Substance Use Treatment and Recovery Team (START), Usual Care
Opioid Use Disorder Clinical Trial 2023: Substance Use Treatment and Recovery Team (START) Highlights & Side Effects. Trial Name: NCT05086796 — N/A
Substance Use Treatment and Recovery Team (START) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05086796 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment process currently open for participants in this research?

"Correct. The information present on clinicaltrials.gov attests that this trial, which was initially posted on November 11th 2021, is currently recruiting for 414 individuals from 3 distinct medical centres."

Answered by AI

How many participants are there in the current clinical trial?

"A total of 414 qualified individuals must join this medical trial. Patricipants can enlist from the University of New mexico Hospital in Albuquerque, NM or Baystate Medical Center located in Springfield, MA."

Answered by AI

What are the primary goals this clinical experiment seeks to accomplish?

"This 30-day clinical trial will primarily measure the rate of MOUD therapy initiation in hospital. Secondary objectives focus on OUD-specific discharge plans, post-discharge MOUD use and outpatients medical care within a month after leaving the hospital."

Answered by AI
~31 spots leftby Jun 2024